Multi-omics analysis of MRPL-13 as a tumor-promoting marker from pan-cancer to lung adenocarcinoma

Xugang Zhong; Zeju He; Yong Fan; Li Yin; Zheping Hong; Yu Tong; Qing Bi; Senbo Zhu

doi:doi:10.18632/aging.205104

← Back

Research Paper Volume 15, Issue 19 pp 10640—10680

Multi-omics analysis of MRPL-13 as a tumor-promoting marker from pan-cancer to lung adenocarcinoma

Figure 9. Drug sensitivity analysis of PNPO and the genes that MRPL13-related. (A) Trametinib. (B) Vorinostat. (C) SB590885. (D) VX−11e. (E) Bleomycin. (F) CI-1040. (G) Navitoclax. (H) TGX221. (I) Nutlin-3A. (J) Correlation between GDSC drug sensitivity and the genes that MRPL13-related.